Reported Aug 3, 2022 · Terminated
Insulin Glargine (Insulin glargine-yfgn) Injection, 100 units/mL (U-100), 3 mL prefilled pens (NDC 49502-394-71),…
Mylan Pharmaceuticals Inc.
High riskUsing this product could cause serious injury, illness or death — stop using it now.What you should do
Stop using the affected lot and contact the recalling firm for the return or refund process. Check the FDA enforcement report for lot-level detail.
Firm contact: Mylan Pharmaceuticals Inc · 5005 Greenbag Rd · Morgantown, WV · 26501-7124
Is this the product you have?
- Insulin Glargine (Insulin glargine-yfgn) Injection, 100 units/mL (U-100), 3 mL prefilled pens (NDC 49502-394-71), packaged in cartons of 5 prefilled pens (NDC 49502-394-75), Rx only
- Manufactured byMylan Pharmaceuticals Inc., Morgantown, WV 15317
- Manufactured forMylan Specialty L.P., Morgantown, WV
- Lot codes and dates
Lot #: BF21002895Exp. Date Aug 2023
- Amount recalled
- 253,200 pens (50,650/5 per packs)
Where it was sold
- Nationwide
Why it was recalled
Stop using this product now
Labeling: Missing label: Label missing from some prefilled pens.
Using this product could cause serious injury, illness or death — stop using it now.
Want the full recall guide?
The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.
Free recall alerts
Get alerted about new Mylan Pharmaceuticals Inc. recalls
One email when a matching recall is published. No account, no cost, unsubscribe in one click.
We email you about recalls and nothing else. Every send has a one-click unsubscribe, and you can change your preferences any time without an account.